Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 92.29MEnterprise Value
VS
Market
Sector
Industry
History
$ 4.81Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information
Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADVERUM BIOTECHNOLOGIES INC - Enterprise Value Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADVM - EV Historical data
| Date | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
|---|---|---|---|---|
| 6/30/2025 | $ 44.39M | $ 84.86M | $ 92.29M | $ 51.83M |
| 3/31/2025 | $ 51.14M | $ 85.95M | $ 77.85M | $ 43.03M |
| 12/31/2024 | $ 62.63M | $ 86.04M | $ 90.89M | $ 67.48M |
| 9/30/2024 | $ 94.83M | $ 62.6M | $ 124.63M | $ 156.85M |
| 6/30/2024 | $ 129.3M | $ 63.31M | $ 69.01M | $ 135M |
| 3/31/2024 | $ 151.58M | $ 63.99M | $ 111.88M | $ 199.47M |
| 12/31/2023 | $ 76.98M | $ 64.63M | $ 355.01M | $ 367.36M |
| 9/30/2023 | $ 108.02M | $ 65.2M | $ 49.12M | $ 91.93M |
| 6/30/2023 | $ 113.84M | $ 65.76M | $ 136.74M | $ 184.82M |
| 3/31/2023 | $ 70.06M | $ 71.35M | $ 85.78M | $ 84.48M |
Key Performance Insights, Last 5 Years
- ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) EV stands at $ 1.14B.
- Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average EV has been $ 258.93M.
- The median EV for ADVERUM BIOTECHNOLOGIES INC during this period was $ 118.25M
- ADVERUM BIOTECHNOLOGIES INC reached its highest EV over the past 5 years at $ 1.27B.
- The lowest EV recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe $ 49.12M
ADVERUM BIOTECHNOLOGIES INC's EV vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV Benchmarks
Similar metrics to Market Cap:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Enterprise Value
[Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].Market Cap + Debt - CashnEq
(=) EV EV for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Market Cap [ $ 1.19B ] + Debt [ $ 26.75M ] - CashnEq [ $ 73.69M ]
(=) EV [ $ 1.14B ] ADVM - Enterprise Value, Last 5 years
$ 49.12M
Minimum
Sep 30, 2023
$ 1.27B
Maximum
Dec 31, 2020
$ 258.93M
Average
$ 118.25M
Median
EV Benchmark AnalysisMarket
The chart above depicts the distribution of EV for companies in the Total Stock Market. The average EV of the companies is $ 1.25B with a standard deviation of $ 1.67B.
The following table provides additional summary stats:
EV in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | $ -1.69B |
| max | $ 6.88B |
| average | $ 1.25B |
| median | $ 439.6M |
| std | $ 1.67B |